Regeneron Pharmaceuticals Inc (REGN)

Receivables turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	US$ in thousands	14,202,000	13,044,200	12,113,500	16,014,400	8,440,200
Receivables	US$ in thousands	6,211,900	5,667,300	5,328,700	6,036,500	3,111,500
Receivables turnover		2.29	2.30	2.27	2.65	2.71

December 31, 2024 calculation

Receivables turnover = Revenue ÷ Receivables
= $14,202,000K ÷ $6,211,900K
= 2.29

The receivables turnover for Regeneron Pharmaceuticals Inc has exhibited a declining trend over the past five years. In December 31, 2020, the receivables turnover was 2.71, and it decreased to 2.65 by December 31, 2021. Further decline was observed in the following years, reaching 2.27 in December 31, 2022, 2.30 in December 31, 2023, and 2.29 in December 31, 2024.

This trend suggests that the company is taking longer to collect payments from its customers over the years. A decreasing receivables turnover may indicate potential issues with credit policies, collection procedures, or the quality of customers. Management should closely monitor receivables turnover and take necessary steps to improve the efficiency of collecting outstanding balances to maintain healthy cash flows and working capital management.